Immune to Cancer: The CRI Blog
-
ASCO 2015: Report from Day 5
The last day of the ASCO meeting featured talks on immunotherapy for pancreatic cancer, one the deadliest…
-
ASCO 2015: Report from Day 4
More cancers prove treatable with checkpoint blockade therapy. Today: kidney, bladder, and ovarian cancer.
-
ASCO 2015: Report from Day 3
Immunotherapy for brain cancer and the results of a large clinical trial for patients with advanced melanoma.
-
ASCO 2015: Report from Day 2
The latest results from clinical trials of checkpoint inhibitors for lung cancer, liver cancer, and more.
-
ASCO 2015: Report from Day 1
A day for travel and educational sessions at the American Society of Clinical Oncology (ASCO).
-
ASCO 2015: 3 Tips for Patients
Tips for patients looking to follow the breaking cancer treatment news from ASCO 2015
-
ASCO 2015: What to Watch in Immunotherapy
Curious about what immunotherapy breakthroughs are coming at ASCO? Here’s a preview.
-
Going “Through the Kitchen” For a Good Cause
CRI's 33rd annual party at the Four Seasons restaurant raises record $1.42 million for cancer immunology research.
-
Twitter Chat: Melanoma and Immunotherapy
Join the #ImmunoChat conversation on May 19 at 4:00 p.m. ET.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.